| Submit your comments on this article |
| Science & Technology |
| COVID-19: Blood cancer patients gain antibodies from vaccine booster - study |
| 2022-07-11 |
| [JP] Blood cancer patients, already at high risk, often did not develop antibodies against COVID-19 from the first shot. But the booster and antibody therapy can provide a better shield. Many adults suffering from blood cancers who did not develop antibodies from their first dose of the COVID-19 vaccine managed to do so after receiving the booster shot, a new study has found. In addition, receiving antibody alongside the second dose can further shield patients from the virus. Patients suffering from blood cancers are at high risk of developing a severe case of the disease after being infected with the novel coronavirus SARS-CoV-2, which causes COVID-19. However, the fact that many do not develop immune responses to initial vaccination has raised concerns. The findings of this study, published in the peer-reviewed academic journal Cancer, raises hopes for protecting these high-risk cancer patients from the global pandemic. |
| Posted by:Besoeker |
| #3 The vaccines have become Cowbell for everything that ails us. I would make an allusion to a medicine show but one metaphor is enough for two sentences. |
| Posted by: Super Hose 2022-07-11 11:21 |
| #2 I just think Cancer is not a good name for a peer reviewed academic journal. That's all. |
| Posted by: Dron66046 2022-07-11 10:48 |
| #1 the novel coronavirus Is there a paperback version? |
| Posted by: Skidmark 2022-07-11 10:36 |